Wellnex Life to give ASX health and wellness sector a shot in the arm

Australia’s health and wellness sector is poised for a shake up as Wellnex Life and its extensive portfolio of more than 15 brands enter the Australian Stock Exchange.

Australia’s health and wellness sector is poised for a shake up as Wellnex Life and its extensive portfolio of more than 15 brands enter the Australian Stock Exchange.

The company, which was formerly nutritional dairy outfit Wattle Health, is set for relisting after undergoing a corporate refresh designed to reposition the business.

The newly-named Wellnex Life will enter the ASX with annualised revenues of roughly $20+ million and an extensive network of pre-existing distribution channels, including a ten-year deal with the nation’s largest pharmacy chain, Chemist Warehouse.

Wellnex Life also has distribution agreements with Coles, Woolworths, Priceline Pharmacies, Sigma Pharmaceuticals, and Australian Pharmaceutical Industries (API).

 

The BSA solution

The decision to acquire health and wellness branding company BSA, followed an extensive strategic review to identify new market opportunities, which would complement the then-Wattle Health’s existing product range.

BSA was founded by Zack Bozinovski in 2010, and has since grown to become a leading figure in the $5.6 billion health and wellness market (which is expected to grow to $7 billion by the end of 2023)

Wattle Health and BSA have a proven track record working together, with BSA successfully getting Wattle’s Uganics brand onto the shelves of leading retailers around the country.

Wellnex Life CEO George Karafotias, said the acquisition remains true to what Wattle Health originally set out to achieve – “innovate, develop, and grow Australian health and wellness products”.

“BSA, with its product development expertise and strong retail customer relationships across pharmacy and grocery, positions us strongly to achieve this at greater scale,” he added.

Wellnex Life intends to target the significant vitamin and dietary supplements segment of this market, which is currently worth roughly $3.1 billion domestically, with plans to expand into the  $1.31 billion sports nutrition segment going forward.

To stay up to date with the latest company news and announcements, register your details on their investor centre.

 

Reach Corporate are engaged as a Corporate Advisor for Wellnex Life and Reach Markets or Reach Corporate may receive fees depending on whether an offer is taken up by investors.

 

Sources:

This Week’s News

News

28 October 2024

Aussie Tech unlocking big data for a $1 trillion Industry

News

15 October 2024

How this Aussie Tech delivers 100x lower costs to a $230 billion market

News

8 October 2024

The Australian AI company aiming for a $1 billion+ exit

General Advice Warning

Any advice provided by Reach Markets including on its website and by its representatives is general advice only and does not consider your objectives, financial situation or needs, and you should consider whether it is appropriate for you. This might mean that you need to seek personal advice from a representative authorised to provide personal advice. If you are thinking about acquiring a financial product, you should consider our Financial Services Guide (FSG)

including the Privacy Statement and any relevant Product Disclosure Statement or Prospectus (if one is available) to understand the features, risks and returns associated with the investment.

Please click here to read our full warning.